WAT News and Press, Waters Corporation From 10/24/23

Waters Corporation Announces Business Unit Leadership Transition PR Newswire Jonathan Pratt to Step Down to Pursue an External Opportunity Christos Ross Named Interim Senior Vice President of the Waters Division MILFORD, Mass. , Oct. 24, 2023 ...

Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and Kits PR Newswire News Summary: Delivers up to 2x [i] higher oligonucleotide recovery from biofluids with improved LC-MS sensitivity and reproducibility to support ...

2023-10-11 17:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Waters Corporation Schedules Third Quarter 2023 Earnings Conference Call PR Newswire MILFORD, Mass. , Oct. 10, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q3 2023 financial results conference call live on Tuesday, November 7th , 2023 ...

2023-10-04 03:04:43 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...

2023-10-02 03:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-10-01 16:02:12 ET Bernstein is bullish on medtech stocks Thermo Fisher, Guardant Health, Revvity and PacBio, but sees further downside for Illumina, according to a new industry note. The investment firm kicked off coverage of the US life science tools and diagnostics sector last we...

2023-09-27 18:07:02 ET Summary Waters Corporation has pushed lower into H2 FY'23, in continuation of the longer-term downtrend. WAT's acquisition of Wyatt Technology was a large premium that to me signaled a lack of profitable investment runway. Despite exceptional returns on ...

2023-09-27 18:00:59 ET Summary Waters Corporation has seen a significant hit to its share price as momentum has left the life sciences tools space and as spending from the key biopharma end-market has corrected. Biopharma spending likely won't return to the torrid pace of the boom...

2023-09-26 16:14:57 ET Summary Demand from biopharmas for life sciences equipment has not sustained high expectations in 2023, leading to weaker growth and negative revisions for companies like Agilent. Biopharma and industrial companies have significantly pulled back on spending ...